Bioventus (BVS) Gains from Investment Securities (2021 - 2024)
Bioventus (BVS) posted Gains from Investment Securities of $345000.0 for Q4 2024, down 28.57% on a QoQ basis from $483000.0 in Q3 2024, and up 18.97% year-over-year from $290000.0 in Q1 2024.
Bioventus (BVS) Gains from Investment Securities (2021 - 2024) Analysis & Trends
Bioventus' Gains from Investment Securities history runs 4 years deep, the most recent figure standing at $345000.0 for Q4 2024.
- Quarterly Gains from Investment Securities rose 18.97% year-over-year to $345000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $345000.0 (down 74.78% YoY) and the FY2024 annual result came in at $1.4 million, up 97.91% from the prior year.
- Gains from Investment Securities was $345000.0 for Q4 2024 at Bioventus, down from $483000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $651000.0 in Q4 2021 and bottomed at -$463000.0 in Q4 2021.
- A 4-year average of $271533.3 and a median of $287000.0 in 2023 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities slumped 135.25% — and 2024, when it surged 592.86%.
- Bioventus' Gains from Investment Securities stood at -$463000.0 in 2021, then soared by 160.91% to $282000.0 in 2022, then rose by 2.84% to $290000.0 in 2023, then increased by 18.97% to $345000.0 in 2024.
- Business Quant data shows BVS's Gains from Investment Securities at $345000.0 in Q4 2024, $483000.0 in Q3 2024, and $300000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Bioventus | 837.84 Mn | 801.99 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 345,000.00 |
| Dec 31, 2024 | 345,000.00 |
| Sep 28, 2024 | 483,000.00 |
| Sep 28, 2024 | 483,000.00 |
| Jun 29, 2024 | 300,000.00 |
| Jun 29, 2024 | 300,000.00 |
| Mar 30, 2024 | 295,000.00 |
| Mar 30, 2024 | 295,000.00 |
| Dec 31, 2023 | 290,000.00 |
| Dec 31, 2023 | 290,000.00 |
| Sep 30, 2023 | -98,000.00 |
| Sep 30, 2023 | -98,000.00 |
| Jul 1, 2023 | 240,000.00 |
| Jul 1, 2023 | 240,000.00 |
| Apr 1, 2023 | 287,000.00 |
| Apr 1, 2023 | 287,000.00 |
| Dec 31, 2022 | 282,000.00 |
| Dec 31, 2022 | 282,000.00 |
| Oct 1, 2022 | 278,000.00 |
| Oct 1, 2022 | 278,000.00 |